Comparison of the Protective Properties of Four
|
|
- Marcia McCarthy
- 5 years ago
- Views:
Transcription
1 Comparison of the Protective Properties of Four Clinical Crystalloid Cardioplegic Solutions in the Rat Heart Lary A. Robinson, M.D., Mark V. Braimbridge, F.R.C.S., and David J. Hearse, D.Sc. ABSTRACT Although few surgeons dispute the benefits of high-potassium crystalloid cardioplegia, objective comparison of the efficacy of various formulations is difficult in clinical practice. We compared four commonly used cardioplegic solutions in the isolated rat heart (N = 6 for each solution) subjected to 180 minutes of hypothermic (20 C) ischemic arrest with multidose cardioplegia (3 minutes every half-hour). The clinical solutions studied were St. Thomas Hospital solution, Tyers solution, lactated Ringer s solution with added potassium, and a balanced saline solution with glucose and potassium. Postischemic recovery of function was expressed as a percentage of preischemic control values. Release of creatine kinase during reperfusion was measured as an additional index of protection. St. Thomas Hospital solution provided almost complete recovery of all indexes of cardiac function following ischemia including % recovery of aortic flow,. compared with poor recovery for the Tyers, lactated Ringer s, and balanced saline solutions (20.6 f 6.5%, 12.5 f 6.4%, and 9.6 f 4.2%, respectively) ( p < 0.001). Spontaneous defibrillation was rapid (less than 1 minute) and complete (100%) in all hearts in the St. Thomas Hospital solution group, but much less satisfactory with the other formulations. Finally, St. Thomas Hospital solution had a low postischemic level of creatine kinase leakage, contrasting with significantly higher enzyme release in the other solutions tested ( p < 0.001). Although differences in composition are subtle, all potassium crystalloid cardioplegic solutions are not alike in the myocardial protection they provide. Comparative studies under controlled conditions are important to define which formulation is superior for clinical application. Since the description in 1955 by Melrose and colleagues [l] of the concept of elective cardiac arrest, the use of cold chemical cardioplegic solutions has evolved and received widespread acceptance: 99% of surgical units in From the Heart Research Unit, The Rayne Institute, St. Thomas Hospital, London, England, and the Department of Surgery, Duke University Medical Center, Durham, NC. Presented at the Thirtieth Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, FL, Nov 3-5, Address reprint requests to Dr. Robinson, Section of Thoracic and Cardiovascular Surgery, University of Nebraska Medical Center, 42nd St and Dewey Ave, Omaha, NE the United States are now using this technique clinically [Z]. However, a bewildering variety of cardioplegic solutions and techniques are utilized in clinical practice in the United States and Europe, and objective comparison of these formulations has proven difficult. Numerous studies, summarized by Hearse and associates [3], have compared various solutions with other methods of tissue protection in both experimental and clinical protocols, but aside from one study comparing the German intracellular cardioplegic solutions with the extracellular St. Thomas Hospital formulation [4], there is a dearth of objective data evaluating the crystalloid solutions commonly used in clinical cardiac surgery in the United States. To avoid the limitations and inherent variability of clinical studies, we chose the isolated working rat heart model [3, 5, 61 to compare the efficacy of myocardial protection provided by four commonly used clinical cardioplegic solutions during prolonged (three hours) hypothermic ischemic arrest. We sought to test the validity of the widely held belief that all cold highpotassium crystalloid cardioplegic solutions are similar in effectiveness. Materials and Methods Hearts were obtained from male Sprague-Dawley rats ranging in weight from 200 to 250 gm. In all studies, the National Academy of Sciences Guide for the Care and Use of Laboratory Animals was followed (National Institutes of Health Publication 80-23, revised 1978). Experimental Model The isolated, perfused, working rat heart model employed in this study has been described in detail elsewhere [3, 5, 61. In this left heart preparation, an ultrafiltered (pore size, 5 pm) perfusion medium is utilized (Krebs-Henseleit bicarbonate buffer [7, 81); the buffer has a ph of 7.4, contains 11.1 mmol/l of glucose, and is oxygenated with 95% oxygen and 5% carbon dioxide at 37 C. The perfusate enters the cannulated left atrium at a pressure equivalent to 17 cm H20 and passes into the left ventricle, from which it is spontaneously ejected through an aortic cannula against a hydrostatic pressure equivalent to 100 cm H20 (electrical pacing was not used in this study). Coronary effluent exiting from the right atrium and ventricle can be sampled for biochemical analysis or recirculated with the aortic outflow. Total cardiopulmonary bypass with coronary perfusion maintained may be simulated by clamping the left atrial cannula and introducing perfusion fluid at 37 C into the aorta from a reservoir located 100 cm above the 268
2 ~ ~~~ ~ ~~~ 269 Robinson, Braimbridge, and Hearse: Crystalloid Cardioplegic Solutions in the Rat Heart Table 1. Composition of the Four Crystalloid Cardioplegic Solutions Testeda Heparin ph Solution Na++ C1++ K+ Ca++ Mg++ HC03- Acetate Gluconate Lactate Procaine Dextrose THAM (units) at 20Tb St. Thomas' ~f: 0.06 Hospital Tyers' , Lactated Ringer's t 0.04 D2.5%/0.45%NaCl , "Where appropriate, values are expressed in millimoles per liter. bvalues shown are mean t standard error of the mean. D2.5%/0.45%NaCl = 2.5% dextrose in 0.45% normal saline; THAM = tris(hydroxymethy1)methylamine. heart. With this preparation, which is essentially that described by Langendorff [9], the heart continues to beat but does not perform any external work. Ischemic cardiac arrest may be induced by clamping the aortic cannula. During ischemia, the heart may be maintained at hypothermia (20 C) by means of cooling circuits supplying the water-jacketed heart chamber. Short periods of preischemic coronary infusion of a cardioplegic solution at 20 C may be achieved by use of a reservoir located 60 cm above the heart and attached to a sidearm of the aortic cannula. Card ioplegic Solutions The test solutions used in these studies were St. Thomas' Hospital solution [lo], Tyers' solution [ll], a modified lactated Ringer's solution with potassium as described by various authors [12-141, and a balanced saline solution (2.5% dextrose in 0.45% normal saline) containing glucose as suggested by Roe and colleagues [15] and Lolley and co-workers [16]. The comparative composition and measured ph (at 20 C) of the test solutions are outlined in Table 1. All tests were prepared from commercially available, clinical intravenous solutions in one-liter plastic or glass containers, and all additives were of pharmaceutical quality. All cardioplegic solutions were filtered through a cellulose acetate membrane (pore size, 0.8 Fm) just before use. None of the test solutions were oxygenated. Experimental Time Course Immediately after excision of the heart, the aorta was cannulated and Langendorff perfusion initiated for a 5- minute washout and equilibration period (Fig 1). Left atrial cannulation was accomplished during this time. The perfusion fluid during the 5-minute washout period and subsequent perfusion periods was Krebs-Henseleit bicarbonate buffer (37"C), as described earlier. The heart was converted to a working preparation by terminating retrograde aortic perfusion and initiating left atrial perfusion. During a 20-minute period, control values for aortic and coronary flow rates, peak aortic pressure, heart rate, and electronically differentiated first derivative of aortic pressure (dp/dt) were recorded. At the end of the control period, the atrial and aortic cannulas were clamped and the heart was subjected to a 3-minute pe- riod of hypothermic (20 C) coronary infusion with one of the four test cardioplegic solutions. Infusion was terminated, and the entire heart was maintained in a state of hypothermic 20 C ischemic arrest for 180 minutes. Cardioplegic solution at 20 C was reinfused for 3 minutes every half-hour during this three-hour ischemic period, after which the heart was reperfused initially in the Langendorff mode for 15 minutes with collection of coronary effluent for creatine kinase (CK) determination [17]. During this period, the time from initial postischemic reperfusion until the resumption of regular heart rhythm was noted. If regular rhythm did not resume by the end of the initial 15- minute reperfusion period, the heart was electrically defibrillated. Following the 15-minute reperfusion period, each heart was converted to the working mode for a further 20 minutes and recovery of cardiac function was recorded. At the end of each experiment, all hearts were heated to 110 C for 24 hours for the determination of dry weight. Analysis of Data During the preischemic working control period, the following variables were recorded: heart rate, coronary flow, aortic flow, aortic pressure, and instantaneous differentiation of aortic dp/dt. Cardiac output was derived from the sum of aortic and coronary flows, and stroke volume was obtained by dividing cardiac output by heart rate. Minute work was derived by multiplying cardiac output by systolic pressure. During the working recovery period, the absolute values for the various measured indexes of cardiac function in individual hearts were compared and expressed as a percentage of those values obtained during the preischemic control period. In addition to eliminating any inherent variability among individual hearts, this allowed the recovery of each index of function to be related to the nature and composition of the test cardioplegic solution. Creatine kinase leakage was expressed as international units per 15 minutes per gram of dry weight. At least 6 hearts were used for each condition studied, and all data were expressed as the mean f standard error of the mean. Statistical analysis of the results was made by unpaired Student t test, and statistical significance was assumed when p values were 0.05 or less.
3 270 The Annals of Thoracic Surgery Vol 38 No 3 September ? c 0 z Pre-Ischemic Working Control 3 7 z.rd ~ c o < a 55 $ : Hypothermic Non -Working Post- I sc hemi c Ischemia 20 C Reperfuston Working Table 2. Effect of Composition of Test Cardioplegic Solutions on Postischemic Recovery of Indexes of Cardiac Function and on Enzyme Leakage after 180 Minutes of Hypotherrnic Ischemia St. Thomas Hospital Tyers Lactated Ringer s D2.5%/0.45%NaCl Percent Percent Percent Percent Variable Control Recovewb Control Recovery Control Recover/ Control Recovery Aortic flow (mumin) 69.6 f f f rt 6.5d 66.8 t f 6.4d 69.3 rt f 4.2d Cardiac output 94.8 f f f f 6.2d f 5.2d 90.8 f f 3.p (mumin) Stroke volume 0.31 f _r f _t 5.7d rt 5Bd 0.30 f f 4.4d (mumin) dp/dt (cmhzo/sec) 4,446.0 f f 2.3 5,408.0 f rt 2Ad 4, f 6.1d 4,264.0 f c 6Ad Minute work f * f f 1.8d f 1.6d _t * 1.6d (105dyne-cm/min) Coronary flow 23.9 f f c f r c 7.F 21.2 f f 5.7d (mumin) Aortic pressure c f f f 3.4d ?r f 3.6d f f 6.9e (cm HzO) Creatine kinase 21.1 f f 8.8d 70.4 rt 3.2d f 22.0d leakage (IU/15 min/gm dry weight) Values shown are mean k standard error of the mean (of at least 6 hearts). bafter 35 minutes of reperfusion for all solutions. Only 5 of the 6 hearts in which this solution was used returned to regular rhythm after ischemia; therefore, the values indicated in this column are for 5 hearts. dsignjficance: p < compared with St. Thomas Hospital solution values (Student t test). Sigmficance: p < 0.01 compared with St. Thomas Hospital solution values (Student t test). Results Functional Assessment Table 2 and Figure 2 show the postischemic recovery of various indexes of myocardial function after three hours of hypothermic ischemia for the four test cardioplegic solutions. As is apparent from these data, St. Thomas Hospital solution afforded good cardiac protection with almost complete return of function; aortic flow and cardiac output recovered to 88.1? 1.6% and 88.1 * 1.7% of preischemic levels, respectively. In marked contrast, the other three solutions gave poor protection during this interval, with the best recovery of aortic flow reaching only 20.6 * 6.5% (Tyers solution) and the worst, % (D2.5%/0.45%NaCl). Although there were no significant differences in any of the functional indexes for these three solutions, there were highly significant differences in recovery when they were compared with St. Thomas Hospital solution. On average, St. Thomas Hospital solution gave three to five times greater recovery of hemodynamic indexes than any of the other solutions. The only difference between the four groups that was not statistically significant was the recovery of heart rate. Enzymatic Assessment The marked differences in functional recovery among the various solutions are paralleled by the results for postischemic CK leakage; Figure 3 displays these results. Again, St. Thomas Hospital solution demonstrated better myocardial preservation, allowing the release of significantly less CK (21.1 * 2.5 IU per 15 minutes per gram of dry weight) than the Tyers, lactated Ringer s,
4 271 Robinson, Braimbridge, and Hearse: Crystalloid Cardioplegic Solutions in the Rat Heart c c u u E V v) - & 60- a 0 ST Tyer s LR D NS.u 30 * I c g 10 a Aortic Stroke Minute dpldt Flow Volume Work CardiG output Coronary Flow Fig 2. Postischemic recovery of various functional indexes (expressed as a percentage of their preischemic baseline control value) in groups of hearts perfused with each of the following cardioplegic solutions: St. Thomas (ST), Tyers, lactated Ringer s (LR), and 2.5% dextrose in 0.45% normal saline (D NS). Recovey was measured at the end of a 35-minute repelfusion period following 180 minutes of hypothermic (20 C) ischemia. Each column represents the mean of 6 hearts, and bars represent the standard error of the mean. (dp1dt = first derivative of aortic pressure; * = p < compared with St. Thomas solution; ** = p < 0.01 compared with St. Thomas solution.) and 2.5% dextrose in saline soilutions ( IU, 70.4? 3.2 IU, and 123.5? 22.0 IU per 15 minutes per gram of dry weight, respectively) (see Table 2). Arrhythmia Assessment Immediately following the three-hour ischemic period, measurements were made of the number of hearts that spontaneously defibrillated (number spontaneously converting to regular rhythm) during reperfusion and the duration of reperfusion before returning to normal rhythm. After 15 minutes of reperfusion, hearts not spontaneously converting to regular rhythm were electrically defibrillated. The results (Fig 4) revealed that perfusion with St. Thomas Hospital solution or Tyers solution led to spontaneous defibrillation in all hearts studied, whereas with the other solutions, the number of hearts that required electrical conversion ranged from 16.7% (D2.5%/0.45%NaCl) to 50% (lactated Ringer s solution). A similar trend was observed for the time to return to regular rhythm, with the shortest time for hearts perfused with St. Thomas Hospital solution (0.67 & 0.1 minutes). The other groups were significantly higher: 3.4 & 1.0 minutes (Tyers ), 10.0 & 1.5 minutes (lactated Ringer s), and 2.9 & 0.6 minutes (D2.5%/0.45% NaCl). If early spontaneous defibrillation is considered an indicator of good myocardial protection, St. Thomas Hospital solution again proved superior. Comment The description in 1955 by Melrose and colleagues [l] of a cardioplegic solution for elective arrest had a profound effect on the future conduct of cardiac surgery. However, the dose of potassium citrate chosen proved too large, resulting in myocardial necrosis; therefore, this technique was abandoned for a decade or more. In the early 1970s, the revival of cold chemical cardioplegia using more rational dosages of component ions resulted in the rapid adoption of this technique in clinical cardiac surgery throughout the world [3] so that by 1981, 99% of clinical surgical units in the United States were using it [2]. A large number of cardioplegic solutions had been developed and evaluated. Nearly all were based on potassium in the range of 15 to 35 mmoy liter [MI, and potassium frequently was the only cardioplegic agent. Other components varied widely in terms of the specific additive chosen and its dosage. In most instances, the inclusion of such additives and their dosages were based on theory, rather than definitive and controlled experimental studies. The recent literature abounds with studies in which various cardioplegic solutions have been compared with regard to their efficacy of protection; these have been summarized by Hearse and colleagues [3]. In general, however, comparisons have been with other methods of tissue protection. Jynge and associates [4] performed the only controlled experimental evaluation of cardio-
5 272 The Annals of Thoracic Surgery Vol 38 No 3 September 1984 T*,* I* F Z 60 W 0 40 n 20 0 st. Tyers Lactated D2.5/ Thomorl Ringerr 0.45NaCI Tver s Lactated Ringers DZ NS Fig 3. Creatine kinase release following ischemia in the four test cardioplegic solution groups. Coronary effuent for the first 25 minutes of reperfusion was collected for measurement of enzyme release. Each column represents the mean of 6 hearts, and bars represent the standard error of the mean. (Abbreviations and symbols same as in Fig 2.) 12 L A plegic solutions in which they compared St. Thomas Hospital solution with the German intracellular solutions (Bretschneider and Kirsch). The present study examined four potassium-based clinical cardioplegic solutions commonly used in the United States. Three markers of myocardial protection (functional recovery, CK leakage, and spontaneous defibrillation) were used to assess the relative efficacy of these solutions. Despite the generally high level of protection afforded, not all solutions provided the same extent of protection, and the St. Thomas Hospital solution proved superior in all aspects to the other three. The reasons for the differences among the test solutions include variations in specific components and differences in dosage of those components (see Table 1). Because of complex interactions and dose-response relationships among several of the important basic cations (sodium, potassium, and calcium), variations in dosage of any of these ions in solutions may lead to deleterious effects on postischemic recovery. Tyers solution [ll] differs in several major respects from St. Thomas Hospital solution. The low dose of magnesium used (one-tenth that of St. Thomas ) does not take full advantage of the increased protection afforded by higher concentrations (e.g., 16 mmol/l), as has been demonstrated by controlled dose-response studies [19]. The acetate (27 mmom) and gluconate (23 mmol/l) included in Tyers solution may not be inert anions substituting for chloride, but they may have potential negative effects. Christoffersen and Skibsted [20] found acetate and gluconate to have marked calciumbinding actions, and inclusion of these additives may Fig 4. (Top) Percentage of hearts spontaneously defibrillating to regular rhythm upon reperfusion after three hours of hypothemzic (20 C) ischemia in each cardioplegic solution test group. (Bottom) Time (mean 5 standard error of the mean) to resumption of regular rhythm following ischemia in hearts that spontaneously defibrillated. Each test group contained 6 hearts. (* = p < 0.02; ** = p < 0.02; *** = p < 0.001; all comparisons between St. Thomas solution and other test groups.) affect the level of free ionized calcium. A recent study [21] found the optimal dose of calcium in cardioplegic solution to be 1.2 mmol/l. The calcium level in Tyers solution of 0.9 mmol/l may have been effectively lowered by the addition of acetate and gluconate, and as a consequence may have an adverse effect on the efficacy of this solution as a cardioplegic agent. The solution based on lactated Ringer s prime [ also differs markedly from the St. Thomas Hospital solution, which may account for its inferior cardioprotective effects. Again, the absence of magnesium may be an important deficiency [19]. Equally important is the potential hazard of lactate in infusates [22]. Although the optimal ph for cardioplegic solutions is controversial, many studies [3] suggest that with cooling of the heart, a mildly alkaline solution is advisable, and any buffer used should have a pk value closest to the desired ph to be effective. The pk (at 25 C) for lactate is 3.86; lactate therefore is an inappropriate buffer because its action is outside of the range normally experienced in cardiac tissue. The measured ph of the test lactated Ringer s solution is , and because lactate is the buffer, the
6 273 Robinson, Braimbridge, and Hearse: Crystalloid Cardioplegic Solutions in the Rat Heart ph will tend to stabilize or become lower after use. In a study of the efficacy of various buffers in cardioplegic solution, bicarbonate or phosphate afforded considerable myocardial protection, whereas lactate was detrimental [22]. Thus, a lactate buffer is also not recommended because it adds to intracellular lactate, which accumulates during ischemia and inhibits glycolysis and anaerobic adenosine triphosphate production. The final test solution using D2.5%/0.45%NaCl as its base [15, 161 also differs in composition from the St. Thomas Hospital solution. The level of calcium in this solution (2.4 mmol/l) is twice that found optimal in the only dose-response study in the literature [21], and the efficacy of this solution may suffer as a result. Tris(hydroxymethy1)methylamine buffer is used instead of bicarbonate as the buffering agent. Although it has a favorable pk of 8.08, Tris is less likely to be advantageous during tissue acidosis as, unlike the other buffers, its ability to act as a hydrogen acceptor declines at lower ph values and is likely to be relatively ineffective in severely ischemic tissue. Additionally, Tris penetrates the cell membrane, and has been shown to be toxic in a number of tissues and to exert a negative inotropic effect [23, 241. The other and perhaps most important difference between St. Thomas Hospital solution and D2.5%/0.45% NaCl is the presence of glucose (139 mmol/l) in the formulation. There is an extensive literature suggesting that glucose in combination with insulin and potassium is beneficial to the ischemic myocardium during acute myocardial infarction [25-271, and its use has been similarly advocated in cardioplegic solutions [15, 161 for elective surgical ischemia. However, studies of glucose-containing cardioplegic solutions compared results with former methods of myocardial preservation and not with similar cardioplegic solutions that did not contain glucose. This may explain why Hearse and co-workers [28] found glucose to be deleterious in the isolated rat heart model with a dose-dependent reduction in myocardial protection. The mechanism to explain these detrimental effects of glucose is unknown but may involve stimulation of glycolysis and accumulation of lactate and protons; or, exogenous glucose utilization may replace the energetically favorable glycogen utilization. The solutions used in this study are representative of the formulations in frequent clinical use, but they do not encompass the entire range of crystalloid cardioplegic solutions or additives. In this comparative controlled study, St. Thomas Hospital solution proved superior to the other test solutions for myocardial protection in the isolated rat heart. If the results for this model prove valid in clinical trials, as has been the case in the past [3], our findings have important implications for the practicing surgeon. This work was supported in part by grants from the British Heart Foundation and the St. Thomas Hospital Research Endowments Fund. References 1. Melrose DG, Dreyer B, Bentall HH, Baker JBE: Elective cardiac arrest. Lancet 221, Miller DW, Binford JM, Hessel EA: Results of a survey of the professional activities of 811 cardiopulmonary perfusionists. J Thorac Cardiovasc Surg 83:385, Hearse DJ, Braimbridge MV, Jynge P: Protection of the Ischemic Myocardium: Cardioplegia. New York, Raven, Jynge P, Hearse DJ, de Leiris J, et al: Protection of the ischemic myocardium: ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates. J Thorac Cardiovasc Surg 76:2, Neely JR, Liebermeister H, Battersby EJ, Morgan HE: Effect of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 2i5804, 1967 Hearse DJ, Stewart DA, Braimbridge MV Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res 36:481, 1975 Krebs HA, Henseleit K Untersuchungen uber die Harnstoffbildung im Tierkorper. Hoppe Seylers Z Physiol Chem 210:33, 1932 Umbreit WW, Burns RH, Stauffer JF: Preparation of Krebs- Ringer phosphate and bicarbonate solution. In Manometric Techniques. Minneapolis, Burgess, 1972, p 146 Langendorff 0: Untersuchungen am uberlebeden Saugethierherzen. Pfluegers Arch 61:291, 1895 Jynge P, Hearse JD, Feuvray D, et al: The St. Thomas Hospital cardioplegic solution: a characterization in two species. Scan J Thorac Cardiovasc Surg [Suppl] 30:5, 1981 Tyers GFO, Manley NJ, Williams EH, et al: Preliminary clinical experience with isotonic hypothermic potassiuminduced arrest. J Thorac Cardiovasc Surg 74:674, 1977 Tyers GFO, Hughes HC Jr, Todd GJ, et al: Protection from ischemic cardiac arrest by coronary perfusion with cold Ringer s lactate solution. J Thorac Cardiovasc Surg 67:411, 1974 Fisk RL, Gelfand ET, Callahan JC: Hypothermic coronary perfusion for intraoperative cardioplegia. Ann Thorac Surg 23:58, 1977 Adams PX, Cunningham JN Jr, Trehan NK, et al: Clinical experience using potassium-induced cardioplegia with hypothermia in aortic valve replacement. J Thorac Cardiovasc Surg 75:564, 1978 Roe BB, Hutchinson JC, Fishman NH, et al: Myocardial protection with cold, ischemic, potassium-induced cardioplegia. J Thorac Cardiovasc Surg 73:366, 1977 Lolley DM, Ray JF 111, Meyers WO, et al: Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study. Ann Thorac Surg 26515, 1978 Szoaz GS, Gruber W, Bernt E: Creatine kinase in serum: I. Determination of optimal reaction conditions. Clin Chem 22:50, 1976 Mitchell BA, Litwak RS: Myocardial protection with cold ischemic potassium-induced cardioplegia: an overview. Proc/Am SOC Extracorp Tech 6:127, 1978 Hearse DJ, Stewart DA, Braimbridge MV Myocardial protection during ischemic cardiac arrest: the importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg 75:877, 1978 Christoffersen GRJ, Skibsted LH: Calcium ion activity in physiological salt solutions: influence of anions substituted for chloride. Comp Biochem Physiol52A:317, 1975
7 274 The Annals of Thoracic Surgery Vol 38 No 3 September Yamamoto F, Braimbridge MV, Hearse DJ: Myocardial protection during global ischemia: optimization of the calcium content of the St. Thomas cardioplegic solution (abstract). J Mol Cell Cardiol 15:Suppl 1:272, Hearse DJ, Stewart DA, Braimbridge MV: Myocardial protection during bypass and arrest: a possible hazard with lactate-containing infusates. J Thorac Cardiovasc Surg 72: 880, GiUespie JS, McKnight AT Adverse effects of Tris hydrochloride, a commonly used buffer in physiologic media. J Physiol259561, Turlapaty PDMV, Altura BT, Altura BM: Influence of Tris on contractile responses of isolated rat aorta and portal vein. Am J Physiol235:H208, de Leiris J, Opie LH: Effects of substrates and coronary artery ligation on mechanical performance and on release of lactate dehydrogenase and creatine phosphate in isolated working rat hearts. Cardiovasc Res 12:585, Majid PA, Sharma 8, Meeran MKM, Taylor SH Insulin and glucose in the treatment of heart failure. Lancet 2:937, Opie LH, Owen P: The effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am Heart J 38:310, Hearse DJ, Stewart DA, Braimbridge MV: Myocardial protection during ischemic cardiac arrest possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 7616, 1978
Effect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia
Original Article Effect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia Yunqing Mei, Hua Liu, Cun Long, Bangchang Cheng, Shangzhi Gao and Dayi Hu, Department of Thoracic
More informationCalcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium
Calcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium E. Jack Baker IV, MD, Gordon N. Olinger, MD, and John E. Baker, PhD Department of Cardiothoracic Surgery, Medical
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationOriginal Article. Introduction
Original Article The Effects of Na Movement on Surgical Myocardial Protection: The Role of the Na + -H + Exchange System and Na-Channel in the Development of Ischemia and Reperfusion Injury Ke-Xiang Liu,
More informationof Calcium-Free and Calcium-Containing Solutions
Cold Ischemic Arrest: Comparison of Calcium-Free and Calcium-Containing Solutions F. F. A. Hendriks, Ph.D., J. Jonas, M.D., A. van der Laarse, Ph.D., H. A. Huysmans, M.D., G. L. van Rijk-Zwikker, M.D.,
More informationMyocardial Protection Principles. David J Chambers
David J Chambers Cardiac Surgical Research/Cardiothoracic Surgery The Rayne Institute (King s College London) Guy s & St Thomas NHS Foundation Trust St Thomas Hospital London UK ScanSect, Aarhus, Denmark.
More informationmyocardial protection. during Prolonged Aortic Cross-Clamping wih Cold Blood Potassium Cardioplegia
Mvocardial Protection wih Cold Blood Potassium Cardioplegia during Prolonged Aortic Cross-Clamping Frank P. Catinella, M.D., Joseph N. Cunningham, Jr., M.D., Peter X. Adams, M.D., Steven L. Snively, M.D.,
More informationThe Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest
The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest and Reperfusion on Myocardial Preservation John H. Rousou, M.D., Richard M. Engelman, M.D., William A. Dobbs, Ph.D., and Mooideen
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationM myocardial preservation [l], and may act by antagonizing
Myocardial Preservation Related to Magnesium Content of Hyperkalemic Cardioplegic Solutions at 8 C Tommy R. Reynolds, MD, Gillian A. Geffin, MB, BS, James S. Titus, Dennis D. O Keefe, MD, and Willard M.
More informationExperimental Comparison of Shumway s Technique and Perfusion Cooling
111. Local Cardiac Hypothermia: Experimental Comparison of Shumway s Technique and Perfusion Cooling F. L. Rosenfeldt, F.R.C.S.E., and D. A. Watson, F.R.C.S. ABSTRACT A model of the thermal conditions
More informationfor Improved Topical Car & ac Hypothermia
A Recirtrulating Cooling S stem for Improved Topical Car & ac Hypothermia F. L. Rosenfeldt, F.R.C.S.E., A. Fambiatos, B.Sc., J. PastorizaPinol, C.C.P., and G. R. Stirling, F.R.A.C.S. ABSTRACT A simple
More informationEffects of Cardioplegic Solution on Human Contractile Element Velocity
ORIGINAL ARTICLES Effects of Cardioplegic Solution on Human Contractile Element Velocity Douglas M. Behrendt, M.D., Marvin M. Kirsh, M.D., Kenneth E. Jochim, Ph.D., and Herbert Sloan, M.D. ABSTRACT A technique
More informationSteph ani eph ani Mi M ck i MD Cleveland Clinic
Stephanie Mick MD Stephanie Mick MD Cleveland Clinic Upper hemisternotomy AVR Ascending Aorta MVr Thoracotomy Based Anterior AVR Lateral Thoracotomy Mitral/Tricuspid surgery Robotically assisted surgery
More informationdelnido for Myocardial Protection
delnido for Myocardial Protection Linda B. Mongero, CCP Director of Education and Clinical Performance IV.PERFUSION SYMPOSIUM 3-5 NOVEMBER 2017 TİTANİC HOTEL LARA, ANTALYA IV.PERFUSION SYMPOSIUM 2017 No
More informationRecovery from Cardiac Bypass and Elective Cardiac Arrest
Recovery from Cardiac Bypass and Elective Cardiac Arrest THE METABOLIC CONSEQUENCES OF VARIOUS CARDIOPLEGIC PROCEDURES IN THE ISOLATED RAT HEART By David J. Hearse, David A. Stewart, and Ernst B. Chain
More informationProtection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia
Protection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia Matthias Karck, MD, Gerhard Ziemer, MD, Max Zoeller, MD, Steffen Schulte, MD, Klaus-D. Juergens, MD, Herwig Weisser, MD, and
More information2. Langendorff Heart
2. Langendorff Heart 2.1. Principle Langendorff heart is one type of isolated perfused heart which is widely used for biochemical, physiological, morphological and pharmacological researches. It provides
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationMirsad Kacila*, Katrin Schäfer, Esad Subašić, Nermir Granov, Edin Omerbašić, Faida Kučukalić, Ermina Selimović-Mujčić
& Influence of Two Different Types of Cardioplegia on Hemodilution During and After Cardiopulmonary Bypass, Postoperative Chest-Drainage Bleeding and Consumption of Donor Blood Products Mirsad Kacila*,
More informationIntraoperative Myocardial Protection: Current Trends and Future Perspectives
Intraoperative Myocardial Protection: Current Trends and Future Perspectives Gideon Cohen, MD, Michael A. Borger, MD, Richard D. Weisel, MD, and Vivek Rao, MD, PhD Division of Cardiovascular Surgery, The
More informationTopical Cardiac Cooling by Recirculation: Comparison of a Closed System Using a Cooling Pad
Topical Cardiac Cooling by Recirculation: Comparison of a Closed System Using a Cooling Pad with an Open System Using a Topical Spray Franklin L. Rosenfeldt, M.D., F.R.C.S.E., and Malcolm Arnold, M.B.,
More informationEarly reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage
Evolving Technology/Basic Science Rudd and Dobson Early reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage Donna M. Rudd,
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 20 The Cardiovascular System: The Heart Introduction The purpose of the chapter is to: 1. Learn about the components of the cardiovascular system
More informationPrinciples of Fluid Balance
Principles of Fluid Balance I. The Cellular Environment: Fluids and Electrolytes A. Water 1. Total body water (TBW) = 60% of total body weight 2. Fluid Compartments in the Body a. Intracellular Compartment
More informationGoing on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia
Going on Bypass What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia Circulation Brain Liver Kidneys Viscera Muscle Skin IVC, SVC Pump Lungs R.A. L.V.
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationAtrial Natriuretic Peptide Protects Against Ischemia-Reperfusion Injury in the Isolated Rat Heart
Atrial Natriuretic Peptide Protects Against Ischemia-Reperfusion Injury in the Isolated Rat Heart Kenji Sangawa, MD, Koji Nakanishi, MD, Kozo Ishino, MD, Masahiro Inoue, MD, Masaaki Kawada, MD, and Shunji
More informationE and the heart: Possible role as antioxidant. Acta Vitaminol. Enzymol. 5: 11-22, ) Jolly, S. R., Kane, W. J., Bailie, M. B. et al.
1) Ferrari, R., Visoli, O., Guarnieri, C. et al.: Vitamin E and the heart: Possible role as antioxidant. Acta Vitaminol. Enzymol. 5: 11-22, 1983. 2) Jolly, S. R., Kane, W. J., Bailie, M. B. et al.: Canine
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationC spread clinical use for operative myocardial protection.
Role of Potassium Concentration in Cardioplegic Solutions in Mediating Endothelial Damage Pankaj S. Mankad, FRCS, Adrian H. Chester, BSc, and Magdi H. Yacoub, FRCS National Heart and Lung Institute, London,
More informationAugust, 2015 STATE MEDICAL FACULTY OF WEST BENGAL. Preliminary Examinations for Diploma in Perfusion Technology : DPfT. Paper I ANATOMY & PHYSIOLOGY
August, 2015 STATE MEDICAL FACULTY OF WEST BENGAL Paper I ANATOMY & PHYSIOLOGY Time 3 hours Full Marks 80 Group A Q-1) Write the correct Answer: 10x1 = 10 i) The posterior descending artery is branch of
More informationIt has been shown that the inhibition of Na /H exchange
The Contribution of Na /H Exchange to Ischemia-Reperfusion Injury After Hypothermic Cardioplegic Arrest Takashi Yamauchi, MD, Hajime Ichikawa, MD, Yoshiki Sawa, MD, Norihide Fukushima, MD, Koji Kagisaki,
More informationPHYSIOLOGY MeQ'S (Morgan) All the following statements related to blood volume are correct except for: 5 A. Blood volume is about 5 litres. B.
PHYSIOLOGY MeQ'S (Morgan) Chapter 5 All the following statements related to capillary Starling's forces are correct except for: 1 A. Hydrostatic pressure at arterial end is greater than at venous end.
More informationD depleted of high-energy phosphates, which are necessary
ORIGINAL ARTICLES Effects of Calcium Chloride Administration on the Postischemic Isolated Rat Heart Albert Abbott, Jr, MD, Ronald Hill, MD, Larry Shears, BS, Kay Beamer, MS, Robert Gustafson, MD, and Gordon
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationMajor intra and extracellular ions Lec: 1
Major intra and extracellular ions Lec: 1 The body fluids are solutions of inorganic and organic solutes. The concentration balance of the various components is maintained in order for the cell and tissue
More informationImproving myocardial preservation after the arrest
Opioid Preconditioning: Myocardial Function and Energy Metabolism Daniel C. Sigg, MD, James A. Coles, Jr, MS, William J. Gallagher, BS, Peter R. Oeltgen, PhD, and Paul A. Iaizzo, PhD Departments of Anesthesiology
More informationModule 8: Practice Problems
Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 19
Figure 19-1 Figure 19-2A Figure 19-2B Figure 19-3 Figure 19-4A1 Figure 19-4A2 Figure 19-4B Figure 19-4C Figure 19-4D Figure 19-5 Figure 19-6A Figure 19-6B A Figure 19-7A B Figure 19-7B C Figure 19-7C D
More informationComparison of Flow Differences amoiig Venous Cannulas
Comparison of Flow Differences amoiig Venous Cannulas Edward V. Bennett, Jr., MD., John G. Fewel, M.S., Jose Ybarra, B.S., Frederick L. Grover, M.D., and J. Kent Trinkle, M.D. ABSTRACT The efficiency of
More informationCritical coronary stenoses may limit the delivery of OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA
OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA Vivek Rao, MD Gideon Cohen, MD Richard D. Weisel, MD Noritsugu Shiono, MD, PhD Yoshiki Nonami, MD, PhD Susan M. Carson, AHT Joan Ivanov, RN, MSc Michael A.
More informationA Change in Myocardial Preservation Strategies using the Quest Medical MPS 2 System
A Change in Myocardial Preservation Strategies using the Quest Medical MPS 2 System Jim MacDonald, CPC,CCP Clinical Perfusion Services, London Health Sciences Centre London, Ontario, Canada Why the Change
More informationFurthermore, potassium arrest appears to be more protective than coronary perfusion at 28 C.
The Importance of Hyperkalemia in a Cold Perfusion Solution: A Correlative Study Examining Myocardial Function, Metabolism, Tissue Gases, and Substrates William H. Heydorn, M.D., Col, MC, USA, William
More informationPreconditioning is defined as the cardioprotective effects
Preconditioning Prevents Myocardial Stunning After Cardiac Transplantation Roderick W. Landymore, MD, Alexander J. Bayes, MD, J. Thomas Murphy, MD, and John H. Fris, RT King Fahad National Guard Hospital,
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationCCAS CPB Workshop Curriculum Outline Perfusion: What you might not know
CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know Scott Lawson, CCP Carrie Striker, CCP Disclosure: Nothing to disclose Objectives: * Demonstrate how the cardiopulmonary bypass machine
More informationPharmacology & Therapeutics
Pharmacology & Therapeutics 127 (2010) 41 52 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate editor: M. Madhani Cardioplegia
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationIntravenous Fluid Therapy in Critical Illness
Intravenous Fluid Therapy in Critical Illness GINA HURST, MD DIVISION OF EMERGENCY CRITICAL CARE HENRY FORD HOSPITAL DETROIT, MI Objectives Establish goals of IV fluid therapy Review fluid types and availability
More informationTechniques of preservation and storage of the donor
Continuous Perfusion Improves Preservation of Donor Rat Hearts: Importance of the Implantation Phase David K. Nickless, MB, BS, Marc Rabinov, MB, BS, PhD, Stephen M. Richards, PhD, Robert A. J. Conyers,
More informationSAMPLE CHAPTER CHAPTER
2.1 Introduction CHAPTER 2 Cardiovascular Structure and Function One may question why it is important for a biomedical engineer to study physiology. To answer this question, we can begin by recognizing
More informationST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5
HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter
More informationEffect of Sodium Nitroprusside during the Payback Period of Cardiopulmonary Bypass on the Incidence of Postoperative Arrhythmias
Effect of Sodium Nitroprusside during the Payback Period of Cardiopulmonary Bypass on the Incidence of Postoperative Arrhythmias Kit V. Arom, M.D., David M. Angaran, M.S., William G. Lindsay, M.D., William
More informationLimiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions
Limiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions Harold L. Lazar, MD, X. Zhang, MD, Samuel Rivers, BS, Sheilah Bernard, MD, and Richard J. Shemin, MD Department of Cardiothoracic
More informationDBL MAGNESIUM SULFATE CONCENTRATED INJECTION
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION NAME OF MEDICINE Magnesium Sulfate BP DESCRIPTION DBL Magnesium Sulfate Concentrated Injection is a clear, colourless, sterile solution. Each ampoule contains
More informationArun Govindapillai. Submitted in partial fulfilment of the requirements for the degree of Master of Science
Protecting The Aged Heart During Cardiac Surgery: Use Of Del Nido Cardioplegia Provides Superior Functional Recovery In Isolated Hearts by Arun Govindapillai Submitted in partial fulfilment of the requirements
More informationELECTROPHYSIOLOGICAL CHANGES DURING MYOCARDIAL ISCHAEMIA
ELECTROPHYSIOLOGICAL CHANGES DURING MYOCARDIAL ISCHAEMIA 1. Definition of myocardial ischaemia "The blood supply to the myocardium is inadequate" (Opie) "The absence of arterial blood flow" (Jennings)
More informationINDUCED HYPOTHERMIA. F. Ben Housel, M.D.
INDUCED HYPOTHERMIA F. Ben Housel, M.D. Historical Use of Induced Hypothermia 1950 s - Moderate hypothermia (30-32º C) in open heart surgery to protect brain against global ischemia 1960-1980 s - Use of
More informationRyuzo Bessho, MD * David J. Chambers, PhD
EXPERIMENTAL STUDY OF INTERMITTENT CROSSCLAMPING WITH FIBRILLATION AND MYOCARDIAL PROTECTION: REDUCED INJURY FROM SHORTER CUMULATIVE ISCHEMIA OR INTRINSIC PROTECTIVE EFFECT? Ryuzo Bessho, MD * David J.
More informationof Potassium ~ardiopbgic Solution
Comparison of Roller Pump versus Pressurized Bag Administration of Potassium ~ardiopbgic Solution Frederick L. Grover, M.D., John G. Fewel, M.S., John J. Ghidoni, M.D., Edward V. Bennett, Jr., M.D., and
More informationImpact of TOE on delivery of antegrade cardioplegia
Impact of TOE on delivery of antegrade cardioplegia David Canty Senior Lecturer + Director of Simulation Department of Surgery, University of Melbourne Cardiac Anaesthetist Royal Melbourne Hospital + Monash
More informationAtrial fibrillation (AF) is associated with increased morbidity
Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery
More informationMinimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques
Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques Konstadinos A Plestis, MD System Chief of Cardiothoracic and Vascular
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationSURGERY INTERNATIONAL ABSTRACTS OF SURGERY WITH VOLUME 109 NUMBER 1
SURGERY WITH INTERNATIONAL ABSTRACTS OF SURGERY VOLUME 109 NUMBER 1 SELECTIVE HYPOTHERMIA OF THE HEART IN ANOXIC CARDIAC ARREST NORMAN E. SHUMWAY, M. D., RICHARD R. LOWER, M. D., and RAYMOND C. STOFER,
More informationEFFECTS OF SIGMA RECEPTOR LIGAND BD737 IN RAT ISOLATED HEARTS
SCRIPTA MEDICA (BRNO) 80 (6): 255 262, December 2007 EFFECTS OF SIGMA RECEPTOR LIGAND BD737 IN RAT ISOLATED HEARTS Nováková M. Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech
More informationRadnoti Langendorff Constant Pressure Non-Recirculating Pump Driven Isolated Heart System For Mouse EZ
Radnoti Langendorff Constant Pressure Non-Recirculating Pump Driven Isolated Heart System For Mouse Radnoti 2006 Description Qty Part # Base only, for 4-bar stand 1 159950-B4 Stabilizer Bar only, for 4-Bar
More informationHigh Ca Content of Pacemaker Tissues in the Frog Heart
Short Communication Japanese Journal of Physiology, 34, 1117-1121,1984 High Ca Content of Pacemaker Tissues in the Frog Heart Yasuichiro FUKUDA Department of Physiology II, School of Medicine, Chiba University,
More information4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.
Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the
More informationFencl Stewart analysis of acid base changes immediately after liver transplantation
Fencl Stewart analysis of acid base changes immediately after liver transplantation David A Story, Rakesh Vaja, Stephanie J Poustie and Larry McNicol The acid base changes associated with liver transplantation
More informationThe strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?
Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?* Nirupama G. Talwalkar, MD, FCCP; Gerald M. Lawrie, MD, FCCP; Nan Earle, BS; and Michael E. DeBakey, MD, FCCP Background:
More informationAcid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation
Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation Michael Kremke Department of Anaesthesiology and Intensive Care Aarhus University Hospital, Denmark
More informationUNIVERSITY OF BOLTON SCHOOL OF SPORT AND BIOMEDICAL SCIENCES SPORT PATHWAYS WITH FOUNDATION YEAR SEMESTER TWO EXAMINATIONS 2015/2016
LH8 UNIVERSITY OF BOLTON SCHOOL OF SPORT AND BIOMEDICAL SCIENCES SPORT PATHWAYS WITH FOUNDATION YEAR SEMESTER TWO EXAMINATIONS 2015/2016 INTRODUCTION TO HUMAN PHYSIOLOGY MODULE NO: SRB3008 Date: Monday
More informationI Suggest Abnormal Saline
I Suggest Abnormal Saline Sean M Bagshaw, MD, MSc Division of Critical Care Medicine University of Alberta CCCF Oct 27, 2015 2015 Disclosures Salary support: Canada/Alberta government Grant support: Canada/Alberta
More informationUnit 1: Human Systems. The Circulatory System
Unit 1: Human Systems The Circulatory System nourish all cells with oxygen, glucose, amino acids and other nutrients and carry away carbon dioxide, urea and other wastes Purposes Transport chemical messengers
More informationin Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.
Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative
More informationPROTECTIVE EFFECT OF NICORANDIL AS AN ADDITIVE TO THE SOLUTION FOR CONTINUOUS WARM CARDIOPLEGIA
PROTECTVE EFFECT OF NCORANDL AS AN ADDTVE TO THE SOLUTON FOR CONTNUOUS WARM CARDOPLEGA Experiments were designed to assess whether (1) nicorandil given before global low-flow ischemia or (2) included in
More informationFeasibility of Leadless Cardiac Pacing Using Injectable. Magnetic Microparticles
Supplementary Information for Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic Microparticles Menahem Y. Rotenberg, Hovav Gabay, Yoram Etzion and Smadar Cohen. Correspondence to: scohen@bgu.ac.il,
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationChapter 9, Part 2. Cardiocirculatory Adjustments to Exercise
Chapter 9, Part 2 Cardiocirculatory Adjustments to Exercise Electrical Activity of the Heart Contraction of the heart depends on electrical stimulation of the myocardium Impulse is initiated in the right
More informationMWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient
MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient In this CE we will discuss the patient presenting with an acute ST-Elevation Myocardial Infarction (STEMI) Definition: Myocardial
More informationPerfusion for Repair of Aneurysms of the Transverse Aortic Arch
technique This new section is open for technicians to explore the unusual, the difficult, the innovative methods by which perfusion meets the challenge of the hour and produces the ultimate goal - a life
More informationThe Cardiovascular System (Heart)
The Cardiovascular System The Cardiovascular System (Heart) A closed system of the heart and blood vessels The heart pumps blood Blood vessels allow blood to circulate to all parts of the body The function
More informationADVANCED ASSESSMENT Cardiovascular System
ONTARIO BASE HOSPITAL GROUP QUIT ADVANCED ASSESSMENT Cardiovascular System 2007 Ontario Base Hospital Group ADVANCED ASSESSMENT Cardiovascular System AUTHORS Mike Muir AEMCA, ACP, BHSc Paramedic Program
More informationCardiovascular system
BIO 301 Human Physiology Cardiovascular system The Cardiovascular System: consists of the heart plus all the blood vessels transports blood to all parts of the body in two 'circulations': pulmonary (lungs)
More informationJournal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00061-3 for Prediction
More informationAcid Base Balance. Professor Dr. Raid M. H. Al-Salih. Clinical Chemistry Professor Dr. Raid M. H. Al-Salih
Acid Base Balance 1 HYDROGEN ION CONCENTRATION and CONCEPT OF ph Blood hydrogen ion concentration (abbreviated [H + ]) is maintained within tight limits in health, with the normal concentration being between
More informationEffect of ACD Blood Prime on Plasma
Effect of ACD Blood Prime on Plasma Calcium and Magnesium Duncan A. Killen, M.D., Edwin L. Grogan, 11, M.D., Roland E. Gower, M.D., Isabella S. Collins, M.D., and Harold A. Collins, M.D. ABSTRACT The changes
More informationThe arterial switch operation has been the accepted procedure
The Arterial Switch Procedure: Closed Coronary Artery Transfer Edward L. Bove, MD The arterial switch operation has been the accepted procedure for the repair of transposition of the great arteries (TGA)
More informationCARDIOVASCULAR SYSTEM
CARDIOVASCULAR SYSTEM Overview Heart and Vessels 2 Major Divisions Pulmonary Circuit Systemic Circuit Closed and Continuous Loop Location Aorta Superior vena cava Right lung Pulmonary trunk Base of heart
More informationBuffering a Permissive Hypercapnia The Evidence
Buffering a Permissive Hypercapnia The Evidence John Laffey Department of Anesthesia, St Michael s Hospital, University of Toronto, CANADA Disclosures Funding European Research Council [FP-7] Health Research
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More information11/10/2014. Muscular pump Two atria Two ventricles. In mediastinum of thoracic cavity 2/3 of heart's mass lies left of midline of sternum
It beats over 100,000 times a day to pump over 1,800 gallons of blood per day through over 60,000 miles of blood vessels. During the average lifetime, the heart pumps nearly 3 billion times, delivering
More informationAdvanced Resuscitation - Adult
C02A Resuscitation 2017-03-23 17 years & older Office of the Medical Director Advanced Resuscitation - Adult Intermediate Advanced Critical From PRIMARY ASSESSMENT Known or suspected hypothermia Algorithm
More information